Přihlásit se Zaregistrujte se zdarma

Vlastnictví managementu společnosti Lyxor Japan (Topix) (Dr) Ucits

Jaká je hodnota metriky Vlastnictví managementu společnosti Lyxor Japan (Topix) (Dr) Ucits?

Hodnota metriky Vlastnictví managementu společnosti Lyxor Japan (Topix) (Dr) Ucits je 0.00%

Jaká je definice metriky Vlastnictví managementu?



Vlastnictví managementu (Insider Ownership) je poměr akcií vlastněných akcionáři v rámci firmy (akcionáři, kteří vlastní více než 5% společnosti nebo ve funkci ředitele či vedoucího odddělení) a veškerých vydaných akcií.

A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.

A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.

Vlastnictví managementu společností v sektoru Miscellaneous sektor na LSE ve srovnání se společností Lyxor Japan (Topix) (Dr) Ucits

Čemu se věnuje společnost Lyxor Japan (Topix) (Dr) Ucits?

Lyxor UCITS ETF Japan (TOPIX) is an exchange traded fund launched and managed by Lyxor International Asset Management S.A. It invests in the public equity markets of Japan. The fund uses derivatives such as swap agreements to invest in the stocks of companies operating across diversified sectors. It invests in the stocks of large-cap companies. The fund seeks to replicate the performance of the TOPIX Gross Total Return Index, by employing synthetic replication methodology. It was formerly known as Lyxor ETF Japan (TOPIX). Lyxor UCITS ETF Japan (TOPIX) was formed on October 28, 2005 and is domiciled in France.

Firmy s metrikou vlastnictví managementu podobnou společnosti Lyxor Japan (Topix) (Dr) Ucits